Oral abstract| Volume 85, ISSUE 5, SUPPLEMENT , AB55, May 2017

120 Is the New Orbit Score the Solution to Predict Small Bowel Bleeding in Patients Under Chronic Anticoagulation?

      Although several scoring systems based on clinical parameters, such as HAS-BLED or HEMORR2HAGES, have been created to assess the 1-year risk for major bleeding in patients on chronic anticoagulation, they seem inadequate in predicting higher diagnostic yields of small bowel capsule endoscopy (SBCE) or higher rebleeding rates in patients with obscure gastrointestinal bleeding (OGIB). The aim of this study was to evaluate the ability of the new ORBIT score in predicting higher diagnostic yield of SBCE or higher rebleeding rates in chronically anticoagulated patients with OGIB.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect